Announcements Trials

Browse Landscape

Sponsor

Conditions

Myelodysplastic Syndromes 3 Recurrence 1 Primary Myelofibrosis 1 Oligodendroglioma 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Gliosarcoma 1 Glioblastoma 1 Ependymoma 1 Brain Stem Neoplasms 1 Astrocytoma 1

Interventions

Cyclophosphamide 21 Isotretinoin 14 Etoposide 13 Topotecan 12 Irinotecan 12 dinutuximab 10 Temozolomide 10 Magnetic Resonance Spectroscopy 10 Doxorubicin 10 Melphalan 9 sargramostim 8 Vincristine 8 Filgrastim 7 Cisplatin 7 Specimen Handling 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 Granulocyte Colony-Stimulating Factor 6 Carboplatin 6 3-Iodobenzylguanidine 6 X-Rays 5 Phantoms, Imaging 5 Busulfan 5 Biopsy 5 fludarabine 4 etoposide phosphate 4 aldesleukin 4 Thiotepa 4 Stem Cell Transplantation 4 Radiotherapy 4 Nuclear Medicine Department, Hospital 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroblastoma × GRN163L peptide × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡